Growth Metrics

Lexicon Pharmaceuticals (LXRX) Inventory (2017 - 2026)

Lexicon Pharmaceuticals (LXRX) reported Inventory of $276000.0 for Q1 2026, up 37.31% year-over-year from $201000.0 in Q1 2025, and down 1.78% on a QoQ basis from $281000.0 in Q4 2025.

Lexicon Pharmaceuticals (LXRX) has 8 years of Inventory data on file, last reported at $276000.0 in Q1 2026.

  • Quarterly Inventory rose 37.31% year-over-year to $276000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $276000.0 (up 37.31% YoY) and the FY2025 annual result came in at $281000.0, up 21.65% from the prior year.
  • Inventory slipped to $276000.0 in Q1 2026 per LXRX's latest filing, from $281000.0 in the prior quarter.
  • Across five years, Inventory topped out at $636000.0 in Q3 2024 and bottomed at $158000.0 in Q3 2025.
  • The 4-year median for Inventory is $278500.0 (2025), against an average of $328250.0.
  • The widest annual swing landed in 2024, when Inventory jumped 240.12%; it then slumped 75.16% in 2025.
  • Tracing LXRX's Inventory over 4 years: stood at $381000.0 in 2023, then plunged by 39.37% to $231000.0 in 2024, then gained by 21.65% to $281000.0 in 2025, then retreated by 1.78% to $276000.0 in 2026.
  • Per Business Quant, the three latest LXRX Inventory figures stand at $276000.0 (Q1 2026), $281000.0 (Q4 2025), and $158000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 32.00 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 1.77 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 3.10 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 84.03 Mn
10 Lexicon Pharmaceuticals 872.52 Mn 701.87 Mn 20.99 Mn 276,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 276,000.00
Dec 31, 2025 281,000.00
Sep 30, 2025 158,000.00
Jun 30, 2025 168,000.00
Mar 31, 2025 201,000.00
Dec 31, 2024 231,000.00
Sep 30, 2024 636,000.00
Jun 30, 2024 585,000.00
Mar 31, 2024 514,000.00
Dec 31, 2023 381,000.00
Sep 30, 2023 336,000.00
Jun 30, 2023 172,000.00
Jun 30, 2020 3.99 Mn
Mar 31, 2020 4.15 Mn
Dec 31, 2019 4.24 Mn
Sep 30, 2019 4.48 Mn
Jun 30, 2019 4.28 Mn
Mar 31, 2019 4.61 Mn
Dec 31, 2018 4.68 Mn
Sep 30, 2018 4.76 Mn
Jun 30, 2018 2.14 Mn
Mar 31, 2018 2.11 Mn
Dec 31, 2017 1.95 Mn
Sep 30, 2017 2.15 Mn
Jun 30, 2017 811,000.00
Mar 31, 2017 236,000.00